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Background: Postmortem redistribution (PMR) refers to the changes that may occur in drug concentrations after
death. Consequently, postmortem concentrations in blood may not always replicate the antemortem drug levels.
Literature supports the model describing drugs with a liver (L) concentration to peripheral blood (P) concentration
ratio less than 5 (L/kg) being prone to little or no PMR. Conversely, drugs with a L/P ratio greater than 20 to 30 (L/
kg) have propensity for substantial PMR.
Findings: Expanding upon this prior work, the current paper presents the concept of a postmortem redistribution
factor (F) for a drug, which characterizes the direct relationship between postmortem peripheral blood and the
corresponding antemortem whole blood concentration.
Conclusions: Development of the concept of a "postmortem redistribution factor" will provide a more definitive
and authoritative drug ranking, and possibly, numerical interpretation of PMR for forensic toxicologists.
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Introduction
A potentially significant issue complicating interpret-
ation of postmortem drug concentrations results from
the phenomenon referred to as postmortem redistribu-
tion (PMR). Postmortem drug concentrations in the
blood may not always straightforwardly parallel antemor-
tem drug concentrations in the blood due to the movement
of the drugs after death. Accordingly, some authors have
argued a cautious approach in interpreting postmortem
concentrations, and others have taken a far more pessimis-
tic and even cynical perspective. The mechanisms involved
in PMR are both complicated and poorly understood. How-
ever, postmortem drug concentrations in the blood may
follow some commonly accepted trends that aid with inter-
pretation. Generally, the characteristics of the drug itself
can be used to predict if a drug is subject to PMR. Substan-
tial changes in blood drug concentrations are predicted for
basic, lipophilic drugs with a high volume of distribution
(>3 L/kg) (Prouty & Anderson 1990). When PMR occurs,
blood specimens drawn from the central body cavity
and heart generally exhibit higher drug concentrationsCorrespondence: iain.mcintyre@sdcounty.ca.gov
Forensic Toxicology Laboratory Manager, County of San Diego Medical
Examiner’s Office, 5570 Overland Ave., Suite 101, San Diego, CA 92123, USA
© 2014 McIntyre; licensee Springer. This is an O
Attribution License (http://creativecommons.or
in any medium, provided the original work is ppostmortem than specimens drawn from peripheral
areas, most commonly the femoral region. Diffusion of
drugs from organ tissues into the blood may explain
the observed phenomenon.
Previous attempts to assess and account for PMR have
utilized postmortem blood specimens collected from at
least two areas of the body at autopsy, a peripheral area
and a central area (often the heart), so that a comparison
could be made. The resulting postmortem blood ratio
was considered to reflect a drug's potential for PMR
(Prouty & Anderson 1990; Dalpe-Scott et al. 1995). Re-
cent work, however, has described ambiguities with this
approach (McIntyre et al. 2012).
The collection, analysis, and comparison of antemor-
tem blood specimens are obviously helpful in assisting
with the interpretation of postmortem blood drug con-
centrations, but relevant specimens are only rarely avail-
able. In a set of case studies of six drugs, concentrations
in the postmortem femoral blood specimens exceeded
the antemortem concentrations in five of the drugs stud-
ied, suggesting that even peripheral blood exhibited
redistribution (Cook et al. 2000). The potential for redis-
tribution of other drugs in postmortem peripheral blood
has also been documented (Gerostamoulos et al. 2012).pen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
McIntyre Journal of Analytical Science and Technology 2014, 5:24 Page 2 of 3
http://www.jast-journal.com/content/5/1/24The liver (L) to peripheral blood (P) ratio has been
proposed as a more dependable marker for PMR, with
ratios less than 5 (L/kg) indicating little to no propensity
towards PMR, and ratios exceeding 20 to 30 (L/kg) indi-
cative of a propensity for substantial PMR (McIntyre
et al. 2012). A number of reports elaborating on,
and supporting, this model have now been published
(McIntyre & Mallett 2012; McIntyre & Meyer Escott
2012; McIntyre & Anderson 2012; McIntyre et al. 2013a;
McIntyre et al. 2013b). Furthermore, a direct correlation
between the postmortem peripheral blood and corre-
sponding antemortem concentration - by consideration
of the L/P ratio - has been expressed (McIntyre et al.
2013c). The report, describing methamphetamine cases,
found that the postmortem peripheral blood concentra-
tions were approximately 1.5 times higher than the cor-
responding concentrations attained in whole blood
specimens collected before death. Given that the L/P ra-
tios for methamphetamine had been confirmed to be ap-
proximately 6 (L/kg), it was then projected that drugs
exhibiting L/P ratios between 5 and 10 (L/kg) would
theoretically yield postmortem peripheral blood concen-
trations up to twice the corresponding antemortem con-
centrations - a measure of PMR potential. It was further
hypothesized that L/P ratios ranging from 10 to 20 (L/
kg) would demonstrate greater potential for PMR with
postmortem peripheral blood concentrations 2 to 3 times
that of the corresponding antemortem levels and conse-
quently even higher L/P ratios indicative of even greater
potential for PMR.
The current document sets out to expound upon this
L/P model and its resultant implications by proposing
the concept of a postmortem redistribution factor (F) for
a drug. The postmortem redistribution factor has been de-
fined as a factor that characterizes the direct relationship
between a drug's postmortem peripheral blood and the cor-
responding antemortem (AM) whole blood concentration.
Hypothesis
Equation 1 presents the proposed relationship between
the antemortem whole blood concentration of a com-
pound and the corresponding postmortem peripheral
blood concentration:
AM¼P=F ð1Þ
where AM = antemortem whole blood concentration,
P = postmortem peripheral blood concentration, and F =
postmortem redistribution factor.
Rearrangement of Equation 1 gives
F¼P=AM ð2Þ
Thus, an example of an experimental (or actual) F
could be determined for a drug where both thepostmortem peripheral blood and antemortem whole
blood drug concentrations have been determined in the
same individual (assuming an insignificant delay between
the collection of the antemortem blood and the time of
death).
Discussion
Considering the methamphetamine data (McIntyre et al.
2013c), an experimental (actual) F for methamphetamine
of 1.5 is predicted - postmortem peripheral blood con-
centrations being 1.5 times (on average) greater than the
corresponding antemortem concentrations.
A related approach to assess potential for PMR has
also recently been described (Launiainen & Ojanpera
2013). This study presented data for 129 drugs comparing
postmortem femoral blood concentrations to therapeutic
plasma concentrations to describe drugs' propensity for
PMR. This study analyzed a large number of cases where
median postmortem drug concentrations were compared
with estimations of the therapeutic concentrations. These
authors projected a similar ratio for methamphetamine of
1.8. Although these data represent a practical attempt to
describe PMR, it is conceivable that the determination of
an F value from analytically determined postmortem data
(such as the unique drug L/P ratio) may well produce more
consistently accurate estimates.
The principal goal of these endeavors was to attempt
to develop a ranking of drugs and indicate their propen-
sity for and, subsequently, their potential extent of PMR.
Until now, most efforts in interpretation have simply de-
scribed PMR by an aphorism, ranging from ‘the drug
has not been found to exhibit PMR’ to ‘the drug is sub-
ject to PMR.’ Such descriptions have never been particu-
larly useful in the interpretation of postmortem drug
concentrations, especially in relation to deducing what
the drug concentration may have been at the time of
death. The development of the concept of a systematic-
ally based postmortem redistribution factor will provide
a more definitive and authoritative ranking and possibly
numerical interpretation of PMR.
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